Predictors of future disease activity in patients with relapsing multiple sclerosis

被引：0
|
作者：
Hutchinson, M
O'Connor, PW
Havrdova, E
Kappos, L
Miller, DH
Phillips, JT
Polman, CH
Lublin, FD
Giovannoni, G
Wajgt, A
Lynn, E
Panzara, MA
Sandrock, AW
机构：
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [31] Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis
    Prosperini, Luca
    Gianni, Costanza
    Barletta, Valeria
    Mancinelli, Chiara
    Fubelli, Federica
    Borriello, Giovanna
    Pozzilli, Carlo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 104 - 112
  • [32] Reducing Rebound Disease Activity in Relapsing Multiple Sclerosis Patients Electively Transitioned from Natalizumab to Teriflunomide
    Cohan, Stanley
    Edwards, Keith
    Gervasi, Tiffany
    Chen, Chiayi
    O'Connor, Judy
    Smoot, Kyle
    Kresa-Reahl, Kiren
    NEUROLOGY, 2017, 88
  • [33] Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity
    Bsteh, Gabriel
    Aicher, Marie L.
    Walde, Janette F.
    Krajnc, Nik
    Haider, Lukas
    Traxler, Gerhard
    Gradl, Christiane
    Salmen, Anke
    Riedl, Katharina
    Poskaite, Paulina
    Leyendecker, Philipp
    Altmann, Patrick
    Auer, Michael
    Berek, Klaus
    Di Pauli, Franziska
    Kornek, Barbara
    Leutmezer, Fritz
    Rommer, Paulus S.
    Zulehner, Gudrun
    Zrzavy, Tobias
    Deisenhammer, Florian
    Chan, Andrew
    Berger, Thomas
    Hoepner, Robert
    Hammer, Helly
    Hegen, Harald
    NEUROLOGY, 2024, 103 (06)
  • [34] Dietary habits in patients with relapsing-remitting multiple sclerosis and their correlation with clinical signatures of disease activity
    Passlick, Johanna
    Fleck, Ann-Katrin
    Lauks, Sarah
    Eveslage, Maria
    Bergh, Florian Then
    Kuempfel, Tania
    Bittner, Stefan
    Zipp, Frauke
    Wiendl, Heinz
    Klotz, Luisa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 821 - 822
  • [35] Effect of Natalizumab on Clinical and Radiological Disease Activity in a French Cohort of Relapsing Remitting Multiple Sclerosis Patients
    Melin, Annick
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Fleury, Marie
    Zephir, Helene
    Lacour, Arnaud
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Vermersch, Patrick
    De Seze, Jerome
    NEUROLOGY, 2011, 76 (09) : A71 - A71
  • [36] Impact of immunotherapy and disease activity on retinal hyperreflective foci in patients with early relapsing remitting multiple sclerosis
    Feil, Tiziana
    Aly, Lilian
    Wicklein, Rebecca
    Utpadel-Fischler, Daniel
    Berthele, Achim
    Hemmer, Bernhard
    Knier, Benjamin
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 779 - 780
  • [37] Coping strategies in relapsing–remitting multiple sclerosis non-depressed patients and their associations with disease activity
    Gabriella Santangelo
    Marida Della Corte
    Maddalena Sparaco
    Giuseppina Miele
    Federica Garramone
    Maria Cropano
    Sabrina Esposito
    Luigi Lavorgna
    Antonio Gallo
    Gioacchino Tedeschi
    Simona Bonavita
    Acta Neurologica Belgica, 2021, 121 : 465 - 471
  • [38] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato De Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Lopes, Josiane
    De Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Borelli, Sueli Donizete
    Kaimen-Maciel, Damacio Ramon
    Vissoci Reiche, Edna Maria
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 1010 - 1020
  • [39] Myelin deterioration occurs in relapsing remitting multiple sclerosis patients meeting criteria for "no evidence of disease activity"
    Harel, A.
    Sperling, D.
    Petracca, M.
    Ntranos, A.
    Brandstadter, R.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 245 - 245
  • [40] Effect of intravenous methylprednisolone on MRI metrics of disease activity in relapsing-remitting multiple sclerosis patients
    Frank, JA
    Rao, AB
    Howard, T
    Bash, CN
    Richert, ND
    Lewis, BK
    McFarland, HF
    NEUROLOGY, 2001, 56 (08) : A460 - A460
12345